Editorial Policy

1. Who writes the articles

The ClascoteroneX Editorial Team researches and writes each article. Because the team works for the company that sells ClascoteroneX, we disclose that commercial interest here and in every byline.

2. Sources

• We prioritise primary sources: peer-reviewed papers, trial registrations (ClinicalTrials.gov) and regulator documents such as FDA labels.
• Company press releases are cited only as company statements.
• Drug-trial results for clascoterone are not results of the ClascoteroneX cosmetic product, and we say so.

3. Updates and corrections

Each article shows its publish date and last-updated date. If you spot an error, contact us through the Contact page and we will review and correct it.